These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10736089)

  • 1. Beta 2-microglobulin/CD8 -/- mice reveal significant role for CD8+ T cells in graft rejection responses in beta 2-microglobulin -/- mice.
    Freland S; Ljunggren HG
    Scand J Immunol; 2000 Mar; 51(3):219-23. PubMed ID: 10736089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cells.
    Jhaver KG; Rao TD; Frey AB; Vukmanović S
    J Immunol; 1995 Jun; 154(12):6252-61. PubMed ID: 7759863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha beta TCR+ cells are a minimal fraction of peripheral CD8+ pool in MHC class I-deficient mice.
    Nesić D; Santori FR; Vukmanović S
    J Immunol; 2000 Aug; 165(4):1896-901. PubMed ID: 10925270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
    Lamousé-Smith E; Clements VK; Ostrand-Rosenberg S
    J Immunol; 1993 Dec; 151(11):6283-90. PubMed ID: 8245467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
    Apasov S; Sitkovsky M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of CD8 alpha alpha+ intestinal intraepithelial T cells in beta 2-microglobulin- and/or TAP1-deficient mice.
    Fujiura Y; Kawaguchi M; Kondo Y; Obana S; Yamamoto H; Nanno M; Ishikawa H
    J Immunol; 1996 Apr; 156(8):2710-5. PubMed ID: 8609387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice.
    Ljunggren HG; Van Kaer L; Sabatine MS; Auchincloss H; Tonegawa S; Ploegh HL
    Int Immunol; 1995 Jun; 7(6):975-84. PubMed ID: 7577806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
    Apasov SG; Sitkovsky MV
    J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R; Ohlén C; Höglund P; Kärre K
    J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of discordant skin xenografts by CD4- CD8- TCR alpha beta+ cells in CD4- and CD8-deficient mice.
    Umesue M; Mayumi H; Kong YY; Omoto K; Muranaka H; Nakanishi R; Kohno H; Yasumoto K; Kishihara K; Nomoto K
    Transplant Proc; 1999; 31(1-2):890-1. PubMed ID: 10083391
    [No Abstract]   [Full Text] [Related]  

  • 12. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.
    Denkers EY; Gazzinelli RT; Martin D; Sher A
    J Exp Med; 1993 Nov; 178(5):1465-72. PubMed ID: 8228800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes.
    Taylor SF; Bender BS
    Immunol Lett; 1995 May; 46(1-2):67-73. PubMed ID: 7590931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential reactivity of residual CD8+ T lymphocytes in TAP1 and beta 2-microglobulin mutant mice.
    Ljunggren HG; Van Kaer L; Ashton-Rickardt PG; Tonegawa S; Ploegh HL
    Eur J Immunol; 1995 Jan; 25(1):174-8. PubMed ID: 7843229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.
    Koller BH; Marrack P; Kappler JW; Smithies O
    Science; 1990 Jun; 248(4960):1227-30. PubMed ID: 2112266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of CD4+ and CD8+ T cells in discordant skin xenograft rejection.
    Uchida T; Tomita Y; Anzai K; Zhang QW; Yoshikawa M; Kishihara K; Nomoto K; Yasui H
    Transplantation; 1999 Dec; 68(11):1721-7. PubMed ID: 10609949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism.
    Christianson GJ; Brooks W; Vekasi S; Manolfi EA; Niles J; Roopenian SL; Roths JB; Rothlein R; Roopenian DC
    J Immunol; 1997 Nov; 159(10):4781-92. PubMed ID: 9366402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice.
    Franco MA; Greenberg HB
    J Virol; 1995 Dec; 69(12):7800-6. PubMed ID: 7494291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.